Toronto | January 26, 2024 – Cboe Canada is pleased to welcome return issuer, BMO Asset Management Inc. (“BMO”), for the launch of a new structured outcome ETF. Now trading on Cboe Canada under the symbol ZJAN, the BMO US Equity Buffer Hedged to CAD ETF – January seeks to replicate the income and returns of the S&P 500 index up to a cap, while buffering against losses.  

Aiming to provide investors with the income and appreciation (before fees, expenses, and taxes) of the S&P 500 up to a predetermined cap, ZJAN buffers against the first 15% (before fees, expenses, and taxes) of losses, resetting after a period of a year beginning and ending in January. ZJAN also hedges US dollar exposure back to Canadian dollars.  

“BMO’s latest offering provides easy access to one of the most popular indexes in the market, with added buffer protection for investors. We are honoured that BMO has chosen to return to Cboe Canada as the listing partner for this launch,” remarked Erik Sloane, Chief Revenue Officer of Cboe Canada. “We are incredibly excited to see new products, particularly those with embedded optionality, continue to launch and gain traction on our markets.” 

Investors can trade units of ZJAN through their usual investment channels, including discount brokerage platforms and full-service dealers. Click here for a complete view of all Cboe-listed securities.   

Cboe Canada is home to over 250 unique listings, including ETFs from Canada’s largest ETF issuers, Canadian Depositary Receipts (CDRs), and some of the most innovative Canadian and international growth companies. In Canada, Cboe consistently facilitates more than 20% of all volume traded in Canadian ETFs and over 15% of all volume traded in Canadian-listed companies.   

About Cboe Canada  

Cboe Canada is Canada’s Tier 1 stock exchange for the purpose-driven Innovation Economy, providing a best-in-class listing experience for issuers that are shaping the economies of tomorrow. Fully operational since 2015, Cboe Canada lists investment products and companies seeking an internationally recognized stock exchange that enables investor trust, quality liquidity, and broad awareness including unfettered access to market data. 

Cboe Canada is part of the Cboe Global Markets network, leveraging deep international expertise, industry-leading market intelligence and technology, and unparalleled service to deliver what stakeholders and the world need now, and for the future. 

Cboe powers ETF Market Canada, a user-friendly platform providing investors and advisors with one-stop access to ETF research and analysis. Real-time, institutional-grade data allows users to compare, contrast, and explore the entire universe of 1,200+ Canadian ETFs, free of charge.   

Connect with Cboe Canada: Website |LinkedIn |Twitter| Instagram | Facebook   

About BMO Exchange Traded Funds 

BMO Exchange Traded Funds has been an ETF provider in Canada for more than 12 years, with over 100 strategies, over 23 per cent market share in Canada1, and $97.5 billion in assets under management. BMO ETFs are designed to stay ahead of market trends and provide compelling solutions to help advisors and investors. This includes a comprehensive suite of ETFs developed in Canada for Canadians, such as cost effective core equity ETFs following market leading indexes, and a broad range of fixed income ETFs; solution-based ETFs responding to client demand; and innovation with smart beta ETFs, as well as combining active and passive investing with ETF series of active mutual funds. 

Connect with BMO: Website | LinkedIn | Twitter | Instagram | Facebook   

Cboe Canada Media Contact:
media@cboe.ca

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up for Our Newsletter

Get the latest investment ideas and strategies sent straight to your inbox.

You May Also Like

Forian Announces the Sale of BioTrack to Alleaves

NEWTOWN, PA and DEERFIELD BEACH, FL, Feb. 13, 2023 (GLOBE NEWSWIRE) —…

Endexx Announces Amended Consolidated 10-Q/A: Quarterly Report for The Quarter Ending March 31, 2023, Increasing Year-Over-Year 1013%

Endexx Year Over Year Six Month Revenues Grew 528% CAVE CREEK, AZ, Sept.…

Anebulo Pharmaceuticals Announces Completion of Dosing and Preliminary Data from Part B of its Phase 2 Study of ANEB-001 for Acute Cannabinoid Intoxication

AUSTIN, Texas, January 09, 2023–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical…

Endexx Ushers in a New Era: Strategic Refresh With Executive and Board Enhancements

CAVE CREEK, AZ – (NewMediaWire) – January 17, 2024 – Endexx Corporation (OTCQB: EDXC), a…